Originally published Monday, October 27, 2008 at 12:00 AM
Comments (0)
E-mail article
Print view
ZymoGenetics shares hit as drug trial halted
ZymoGenetics shares took a sharp dive Monday after a trial of its drug to treat kidney disease in lupus patients was discontinued by Merck Serono because of high risk of infection.
Seattle Times business reporter
ZymoGenetics shares fell 29 percent Monday after a trial of its drug to treat kidney disease in lupus patients was discontinued by Merck Serono because of high risk of infection.
The Seattle biotechnology firm said in a securities filing early Monday that Merck halted a mid-stage trial of atacicept in people with systemic lupus erythematosus. ZymoGenetics shares closed at $3.68, down $1.42.
The ZymoGenetics-developed drug began testing in December in combination with therapies that help suppress the immune system. ZymoGenetics says it was the presence of the other drugs — and not atacicept — that caused the infection.
"We think it was the combination ... we haven't seen any signs of infections like this in any of the other trials," said spokeswoman Susan Specht.
Atacicept trials for other ailments such as rheumathoid arthritis and multiple sclerosis are still ongoing, the company said.
ZymoGenetics handed off the development and worldwide rights for atacicept to Merck Serono in early September; it will receive milestone payments and royalties from sales once the product launches.
The discontinuation of the trial could delay the drug's commercialization until 2014, as the safety concerns reduce the possibility of an accelerated review by the U.S. Food and Drug Administration, said Oppenheimer & Co. analyst Kevin DeGeeter in a report.
ZymoGenetics shares have suffered in recent months, as the market seemed disappointed with the slowly growing sales of Recothrom, a compound to control surgical bleeding, which in January became the company's first commercial launch.
Monday's announcement further damaged the stock — now a far cry from its 52-week high of $15.23.
"Until we get data it's really going to weigh on the stock," said Paul Latta, an analyst with McAdams Wright Ragen.
The event is "unfortunate for ZymoGenetics and for lupus patients," said Latta said. "There hasn't been a new treatment for lupus in decades."
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2008 The Seattle Times Company
More Business & Technology headlines...
E-mail article
Print view Share:
Digg
Newsvine
![]()
Nintendo re-enlists Mario, savior of video-game industry
Verizon-Frontier deal stirs concern among consumers
Brier Dudley: 'Guitar Hero' founder excited about future
Gaps for consumers in Democrat health care bills
Hutch gets $10M from Bezos family for immunotherapy research

Real Salt Lake wins MLS Cup
Real Salt Lake defeated the Los Angeles Galaxy with penalty kicks after 120 minutes of play at Qwest Field in Seattle.
general classifieds
Garage & estate salesFurniture & home furnishings
Sporting goods
just listed
8 Drawer Dresser with Attached Mirror - $200
8 seat pecon formal dining table and china hutch - $1500
A American Table, Chairs and Bench - $275
More listings
POST A FREE LISTING
shopping
Give yourself a treat and visit Watson Kennedy's Holiday Open Houses
More minding the store
events for Monday, Nov. 23
- REI Winter Sale
- Alhambra 20 Percent Off Jewelry Sale
- All About Weddings and Celebrations November ...
- Karan Dannenberg Clothier Black Friday Sale
editors' picks
- West Seattle shopping
- Local jewelry designers
- Phinney Ridge & Greenwood shopping
- Neighborhood shopping
- 'The Road' takes Viggo Mortensen to Mount St. Helens and Astoria, Ore.
- Tugboat sinks at Seattle waterfront pier
- Illegal workers quietly let go
- Child-support error costs nearly $21,000
- Vikings easily beat the Seahawks
- Craigslist adoption ad: A plea by young mother-to-be? A scam?
- Chase shrugs off loss of CD investors
- Woman stabbed by stranger in North Seattle
- Snow piles up on Cascade slopes
- Denny Triangle gains skyline, but tenants slow to come
- Illegal workers quietly let go
342 - Climate change speeds up since 1997 Kyoto accord
201 - Vikings easily beat the Seahawks
170 - Metro won't cut bus service after all
140 - Historic health care bill clears Senate hurdle
94 - New Husky recruit: Enes Kanter
86 - Tattoos at Mill Creek Church pierce skin, soul
80 - Jerry Brewer: Seahawks can't lean on the Hutch Crutch now
72 - Middleton says Huskies "plan on scoring at least 50 points'' Saturday
66 - UW, WSU once again meet to see who's worse
65
- Sprouts, raw fish on attorney's 'do not eat' list
- Tattoos at Mill Creek church pierce skin, soul
- Illegal workers quietly let go
- Food-safety lawyer's wish: Put me out of business
- Architects, chefs find 'kid' within to build Gingerbread Village
- Rediscovering Moab, 'the most beautiful place on Earth'
- It's possible to recover a life lost to hoarding
- Child-support error costs nearly $21,000
- 'The Road' takes Viggo Mortensen to Mount St. Helens and Astoria, Ore.
- Taste | The Great Pie Bake-off pits friends and fruit
